Variant report
Variant | nsv581800 |
---|---|
Chromosome Location | chr2:49524316-49539245 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6729203 | chr2:49524316-49524317 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs186454696 | chr2:49524340-49524341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs544141969 | chr2:49524365-49524366 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs144376902 | chr2:49524386-49524387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs538476443 | chr2:49524436-49524437 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs556326241 | chr2:49524443-49524444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs564509767 | chr2:49524474-49524475 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs6714445 | chr2:49524478-49524479 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs189699190 | chr2:49524495-49524496 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs553820668 | chr2:49524507-49524508 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375766583 | chr2:49524530-49524531 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs572418257 | chr2:49524531-49524532 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs527803741 | chr2:49524545-49524546 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs542642393 | chr2:49524550-49524551 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs546800324 | chr2:49524570-49524571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs562044802 | chr2:49524578-49524579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs573850075 | chr2:49524588-49524589 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11125231 | chr2:49524601-49524602 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs116489809 | chr2:49524643-49524644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533116412 | chr2:49524684-49524685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs539466999 | chr2:49524694-49524695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs551524496 | chr2:49524711-49524712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs560257580 | chr2:49524722-49524723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs141362674 | chr2:49524734-49524735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs548696853 | chr2:49524736-49524737 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs111869705 | chr2:49524752-49524753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567987251 | chr2:49524794-49524795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs557755491 | chr2:49524922-49524923 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs150259591 | chr2:49524924-49524925 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550014790 | chr2:49524933-49524934 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs567585953 | chr2:49524943-49524944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571528401 | chr2:49524945-49524946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs368052693 | chr2:49524947-49524948 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs75967245 | chr2:49524949-49524950 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553882043 | chr2:49524952-49524953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs73929136 | chr2:49524997-49524998 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs536699450 | chr2:49525001-49525002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs148253248 | chr2:49525016-49525017 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs554657312 | chr2:49525018-49525019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73929137 | chr2:49525081-49525082 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs544524094 | chr2:49525114-49525115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs182741565 | chr2:49525136-49525137 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs577930999 | chr2:49525167-49525168 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545210325 | chr2:49525179-49525180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs560335260 | chr2:49525180-49525181 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs377599087 | chr2:49525184-49525185 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs115436286 | chr2:49525272-49525273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542664379 | chr2:49525284-49525285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560724026 | chr2:49525285-49525286 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs13404758 | chr2:49525349-49525350 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49524200-49525800 | Weak transcription | Brain Angular Gyrus | brain |
2 | chr2:49525800-49526000 | Enhancers | Brain Angular Gyrus | brain |
3 | chr2:49533800-49534400 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
4 | chr2:49533800-49534400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr2:49533800-49534800 | Enhancers | HUVEC | blood vessel |
6 | chr2:49534000-49534400 | Enhancers | Pancreatic Islets | Pancreatic Islet |
7 | chr2:49534000-49534600 | Enhancers | HepG2 | liver |